- Home
- CURI vs TIL Comparison
CURI vs TIL Comparison
Compare CURI & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURI
- TIL
- Stock Information
- Founded
- CURI N/A
- TIL 2018
- Country
- CURI United States
- TIL United States
- Employees
- CURI N/A
- TIL N/A
- Industry
- CURI Movies/Entertainment
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- CURI Consumer Discretionary
- TIL Health Care
- Exchange
- CURI Nasdaq
- TIL Nasdaq
- Market Cap
- CURI 144.8M
- TIL 171.7M
- IPO Year
- CURI N/A
- TIL 2021
- Fundamental
- Price
- CURI $5.08
- TIL $13.68
- Analyst Decision
- CURI Strong Buy
- TIL Buy
- Analyst Count
- CURI 2
- TIL 5
- Target Price
- CURI $5.40
- TIL $114.00
- AVG Volume (30 Days)
- CURI 943.7K
- TIL 181.7K
- Earning Date
- CURI 05-06-2025
- TIL 05-20-2025
- Dividend Yield
- CURI 2.85%
- TIL N/A
- EPS Growth
- CURI N/A
- TIL N/A
- EPS
- CURI N/A
- TIL N/A
- Revenue
- CURI $54,223,000.00
- TIL N/A
- Revenue This Year
- CURI $14.45
- TIL N/A
- Revenue Next Year
- CURI $10.55
- TIL N/A
- P/E Ratio
- CURI N/A
- TIL N/A
- Revenue Growth
- CURI N/A
- TIL N/A
- 52 Week Low
- CURI $0.98
- TIL $9.62
- 52 Week High
- CURI $5.30
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- CURI 78.21
- TIL 45.90
- Support Level
- CURI $3.21
- TIL $11.97
- Resistance Level
- CURI $5.30
- TIL $14.67
- Average True Range (ATR)
- CURI 0.37
- TIL 2.05
- MACD
- CURI 0.18
- TIL 0.04
- Stochastic Oscillator
- CURI 90.27
- TIL 21.18
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions, and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.